Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bloodletting Puncture in the Treatment of Acute Ischemic Stroke: a Mixed-method Study of a Multi-centre Randomised Controlled Trial and Focus Group

NCT05266326 is registered in ClinicalTrials.gov with Chongqing Traditional Chinese Medicine Hospital as lead sponsor.

NCT NCT05266326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05266326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bloodletting Puncture in the Treatment of Acute Ischemic Stroke: a Mixed-method Study of a Multi-centre Randomised Controlled Trial and Focus Group
Lead sponsor
Chongqing Traditional Chinese Medicine Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 8, 2022
Completion date
December 31, 2022
Enrollment
360 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke